Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
197M
-
Number of holders
-
992
-
Total 13F shares, excl. options
-
184M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$28.4B
-
Value change
-
+$234M
-
Put/Call ratio
-
0.43
-
Number of buys
-
383
-
Number of sells
-
-424
-
Price
-
$154.09
Significant Holders of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) as of Q4 2020
1,092 filings reported holding ZBH - ZIMMER BIOMET HOLDINGS, INC. - Common Stock as of Q4 2020.
ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) has 992 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 184M shares
of 197M outstanding shares and own 93.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (19.4M shares), VANGUARD GROUP INC (15.7M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (10M shares), Capital Research Global Investors (9.24M shares), JPMORGAN CHASE & CO (8.85M shares), STATE STREET CORP (8.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.78M shares), Nuveen Asset Management, LLC (4.36M shares), Invesco Ltd. (4.19M shares), and VIKING GLOBAL INVESTORS LP (3.87M shares).
This table shows the top 992 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.